Monday, June 24, 2013 12:13:28 AM
1. HHSE's line of credit was (supposedly) very misleading such that they won't get much anything from it.
2. But, when pointed out that they did indeed acquire some movies, the story changes that the movies were cheap crap movies.
3. But when pointed out the movies included a Sundance Award-Winner, the story changes that it is an expensive movie that they will lose a lot of money or alternatively that the movie was award winning but crap movie at the same time.
Sure a lot of (at best) negative assuptions especially considering the extremely low valuation ... are there any better companies trading at this valuation ... let me know!
Recent HHSE News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 07:17:02 PM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM